Shelton Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,487
| Closed | -$223K | – | 735 |
|
|
2023
Q3 | $223K | Hold |
2,487
| – | – | 0.01% | 601 |
|
|
2023
Q2 | $212K | Sell |
2,487
-140
| -5% | -$11.9K | 0.01% | 669 |
|
|
2023
Q1 | $217K | Hold |
2,627
| – | – | 0.01% | 638 |
|
|
2022
Q4 | $207K | Sell |
2,627
-187
| -7% | -$14.7K | 0.02% | 633 |
|
|
2022
Q3 | $208K | Buy |
+2,814
| New | +$208K | 0.01% | 618 |
|
|
2021
Q2 | – | Sell |
-2,814
| Closed | -$312K | – | 841 |
|
|
2021
Q1 | $312K | Sell |
2,814
-139
| -5% | -$15.4K | 0.01% | 536 |
|
|
2020
Q4 | $351K | Hold |
2,953
| – | – | 0.02% | 435 |
|
|
2020
Q3 | $258K | Hold |
2,953
| – | – | 0.01% | 583 |
|
|
2020
Q2 | $264K | Sell |
2,953
-153
| -5% | -$13.7K | 0.01% | 481 |
|
|
2020
Q1 | $310K | Sell |
3,106
-193
| -6% | -$19.3K | 0.02% | 379 |
|
|
2019
Q4 | $379K | Sell |
3,299
-161
| -5% | -$18.5K | 0.02% | 437 |
|
|
2019
Q3 | $436K | Hold |
3,460
| – | – | 0.03% | 386 |
|
|
2019
Q2 | $416K | Buy |
3,460
+3,133
| +958% | +$377K | 0.02% | 402 |
|
|
2019
Q1 | $3.74K | Sell |
327
-3,412
| -91% | -$39K | 0.01% | 657 |
|
|
2018
Q4 | $374K | Hold |
3,739
| – | – | 0.03% | 381 |
|
|
2018
Q3 | $428K | Sell |
3,739
-1,405
| -27% | -$161K | 0.02% | 410 |
|
|
2018
Q2 | $461K | Hold |
5,144
| – | – | 0.03% | 373 |
|
|
2018
Q1 | $376K | Buy |
5,144
+445
| +9% | +$32.5K | 0.02% | 451 |
|
|
2017
Q4 | $273K | Hold |
4,699
| – | – | 0.02% | 624 |
|
|
2017
Q3 | $211K | Sell |
4,699
-467
| -9% | -$21K | 0.01% | 759 |
|
|
2017
Q2 | $204K | Buy |
+5,166
| New | +$204K | 0.01% | 805 |
|